急诊就诊后兴奋剂中毒患者的一年死亡率
这项回顾性队列研究利用全州链接数据库,纳入2356例因兴奋剂中毒从急诊出院的患者,主要结局为出院后一年全因死亡率,采用Kaplan-Meier分析。结果显示一年死亡率为2.1%(95%CI 1.6-2.8%),死亡者中位年龄35岁,中位死亡时间118天。67%的死亡由药物过量导致,其中54%涉及阿片类,37%为阿片类与兴奋剂联合涉及。作为参照,1665例阿片类中毒急诊就诊者的一年死亡率为6.9%(95%CI 5.8-8.3%)。结论提示该相对年轻人群出院后死亡风险可观,死亡主要与药物过量相关且常涉及阿片类,支持考虑针对阿片类的减害干预。
要点
- 兴奋剂中毒急诊出院后一年全因死亡率为2.1%(95%CI 1.6-2.8%),死亡者中位年龄仅35岁。
- 死亡者中位死亡时间为出院后118天(IQR 63-228天),出院后数月内仍存在死亡风险。
- 67%的死亡归因于药物过量,其中54%涉及阿片类,37%为阿片类与兴奋剂联合涉及。
- 作为参照,阿片类中毒急诊就诊者一年死亡率为6.9%(95%CI 5.8-8.3%),高于兴奋剂中毒人群。
- 原文结论支持在该人群中考虑以阿片类为重点的减害干预。
适用人群与场景
- 因兴奋剂中毒为主诊断从急诊出院并纳入全州链接数据库的患者;共2356例符合纳入标准。
- 原文未提及排除标准、具体年龄范围或急诊/ICU病情阶段分层。
诊断标准与关键阈值
- 兴奋剂中毒通过国际疾病分类第十版(ICD-10)编码识别,主诊断为兴奋剂中毒。
- 主要结局为急诊出院后一年内全因死亡,采用Kaplan-Meier分析估计。
处置流程与药物剂量
- 原文未提及具体处置流程或药物剂量方案。
- 原文结论支持考虑以阿片类为重点的减害干预,但未给出具体干预措施、剂量或实施方案。
红旗征与不能漏的情况
- 原文未提及具体红旗征或需立刻处理的情况。
- 原文报告67%的死亡由药物过量导致,54%涉及阿片类,37%为阿片类与兴奋剂联合涉及,提示出院后药物过量是主要死亡原因。
研究设计与关键结果
- 研究类型:回顾性队列研究,使用全州急诊与住院出院记录及死亡记录链接数据库,单州数据。
- 样本量:2356例兴奋剂中毒急诊出院患者;参照队列为1665例阿片类中毒急诊就诊患者。
- 主要终点:一年全因死亡率为2.1%(95%CI 1.6-2.8%)。
- 死亡者特征:中位年龄35岁,中位死亡时间118天(IQR 63-228天)。
- 死因构成:药物过量占67%,其中阿片类涉及54%,阿片类与兴奋剂联合涉及37%。
- 参照队列:阿片类中毒急诊就诊者一年死亡率为6.9%(95%CI 5.8-8.3%)。
证据类型、等级与局限
- 证据类型:回顾性队列研究(单州链接数据库)。
- 局限:原文未明确列出局限;设计本身为回顾性、单州数据库、基于ICD-10编码识别,可能存在编码偏倚和未测量混杂。
对床旁实践的改变
- 该研究提示兴奋剂中毒急诊出院患者一年死亡率2.1%,死亡主要与药物过量相关且常涉及阿片类,支持在此人群中考虑以阿片类为重点的减害干预。
- 原文未提供具体干预措施、适用/不适用人群或常见陷阱的细节。
指南或共识出处
- 原文未提及指南或共识出处;本文为发表于Am J Emerg Med的研究论文。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Rising stimulant-related overdose deaths and emergency department (ED) utilization highlight the need to better characterize outcomes following ED encounters for stimulant toxicity. We sought to determine one-year mortality after ED discharge for stimulant toxicity and to characterize the causes of death.
METHODS: This retrospective cohort study used a linked statewide database of ED and hospital discharge records and death records. Patients discharged from the ED with a primary diagnosis of stimulant toxicity, identified by International Classification of Diseases, Tenth Revision (ICD-10) codes, were included. The primary outcome was all-cause mortality within one year of ED discharge, estimated using Kaplan-Meier analysis. A secondary reference analysis was performed among patients with ED visits for acute opioid toxicity to contextualize mortality estimates against a population previously associated with elevated post-discharge mortality.
RESULTS: A total of 2356 patients met inclusion criteria. One-year mortality was 2.1% (95% confidence interval [CI] 1.6-2.8%). Among patients who died within one year, median age at the index visit was 35 years and median time to death was 118 days (interquartile range [IQR] 63-228 days). Overdose accounted for 67% of deaths, with opioids implicated in 54% and combined opioid-stimulant involvement in 37%. In the secondary reference cohort of 1665 opioid-related ED visits, one-year mortality was 6.9% (95% CI 5.8-8.3%).
CONCLUSION: Patients with ED encounters for stimulant toxicity experienced substantial one-year mortality in a relatively young population. Subsequent deaths were predominantly overdose-related and frequently opioid-involved, supporting consideration of opioid-focused harm-reduction interventions in this population.
参考来源
- Idowu D, Yang X, Comstock G, et al. One-year mortality following emergency department visits for stimulant toxicity. Am J Emerg Med. 2026. PMID: 42956443. doi:10.1016/j.ajem.2026.10.032
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。